| Date | Title | | | 03/18/10 | Rigel to Webcast Investor Day on March 25, 2010| SOUTH SAN FRANCISCO, Calif., March 18, 2010 /PRNewswire via COMTEX/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will provide a live webcast for its Investor Day on March 25, 2010 at 10:00am EDT. Members of Rigel's senior management team will provide an overview of the company's current product pipeline.
The event will be webcast live and can be accessed from Rigel's website at www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the l... |
|  | | 03/17/10 | Rigel to Present at Barclays Capital Healthcare Conference| SOUTH SAN FRANCISCO, Calif., March 17, 2010 /PRNewswire via COMTEX/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the Barclays Capital 2010 Global Healthcare Conference in Miami, Florida on Tuesday, March 23 at 10:45 a.m. EDT.
To access the live audio webcast or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website severa... |
| | | 03/05/10 | Rigel to Present at Cowen and Company Health Care Conference| SOUTH SAN FRANCISCO, Calif., March 5, 2010 /PRNewswire via COMTEX/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the Cowen and Company 30th Annual Health Care Conferencein Boston, Massachusetts on Tuesday, March 9th at 3:45 p.m. EST.
To access the live audio webcast or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website... |
| | | 03/02/10 | Rigel Announces Fourth Quarter and Year End 2009 Financial Results| SOUTH SAN FRANCISCO, Calif., March 2, 2010 /PRNewswire via COMTEX/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter and year ended December 31, 2009.
For the fourth quarter of 2009, Rigel reported a net loss of $25.1 million, or $0.48 per share, compared to a net loss of $33.4 million, or $0.91 per share, in the fourth quarter of 2008. Weighted average shares outstanding for the fourth quarters of 2009 and 2008 were 51.8 million and 36.6 mil... |
| | | 02/16/10 | Rigel to Host Conference Call Today to Discuss Its Partnership With AstraZeneca on Fostamatinib Disodium (R788)| SOUTH SAN FRANCISCO, Calif., Feb 16, 2010 /PRNewswire via COMTEX/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) announced that its senior management team will host a conference call, and simultaneous audio webcast, today at 8:30 a.m. EST (5:30 a.m. PST) to discuss its partnership with AstraZeneca for Rigel's late-stage investigational product, fostamatinib disodium (R788), for the treatment of rheumatoid arthritis and additional indications.
Conference Call and Webcast Information
To access t... |
| | | 02/16/10 | AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis (RA)| SOUTH SAN FRANCISCO, Calif., Feb 16, 2010 /PRNewswire via COMTEX/ -- AstraZeneca and Rigel Pharmaceuticals (Nasdaq: RIGL) today announced an exclusive worldwide license agreement for the global development and commercialization of fostamatinib disodium (R788), Rigel's late-stage investigational product for rheumatoid arthritis (RA) and additional indications. Fostamatinib disodium, which has completed a comprehensive phase 2 program, is the furthest developed oral Spleen Tyrosine Kinase (Syk) i... |
| | | 02/05/10 | Rigel to Present at BIO CEO & Investor Conference| SOUTH SAN FRANCISCO, Calif., Feb 05, 2010 /PRNewswire via COMTEX/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the 12th Annual BIO CEO & Investor Conference in New York City on Monday, February 8th at 10:00 a.m. EST.
To access the live audio webcast or the subsequent archived recording, log on to www.rigel.com. Please connect to Rigel's website several min... |
| |
|
rigel in the news
